Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kary

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Der Pathologe|March 1, 1983
[Spurious aneurysm of the heart]S Kary-Berghäuser, F Köhler
International Journal of Clinical Practice|May 2, 2003
Anakinra: the first interleukin-1 inhibitor in the treatment of rheumatoid arthritisS Kary, G R Burmester
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|April 15, 2014
[Not Available]S Kary, G-R Burmester
Bulletin of Environmental Contamination and Toxicology|December 1, 1989
Toxicological aspects of activated sludge feedingE Nachtomi, B Lipstein, S Kary
Der Internist|December 16, 2003
[Pharmacotherapy of rheumatic diseases in the aged]S Kary, F Buttgereit, G R Burmester
Rheumatology (Oxford, England)|June 10, 2004
Do we still miss the chance of effectively treating early rheumatoid arthritis? New answers from a new studyS Kary, J Fritz, H U Scherer, et al.
Annals of the Rheumatic Diseases|July 30, 2008
Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label studyM Rudwaleit, E Rødevand, P Holck, et al.
Rheumatology (Oxford, England)|May 17, 2007
Effectiveness of adalimumab for rheumatoid arthritis in patients with a history of TNF-antagonist therapy in clinical practiceS Bombardieri, A A Ruiz, P Fardellone, et al.
Annals of the Rheumatic Diseases|September 10, 2005
New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor alpha antagonistsS Kary, M Worm, H Audring, et al.
The British Journal of Dermatology|February 16, 2007
Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonistsH-H Lee, I-H Song, M Friedrich, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Der Pathologe|March 1, 1983
[Spurious aneurysm of the heart]S Kary-Berghäuser, F Köhler
International Journal of Clinical Practice|May 2, 2003
Anakinra: the first interleukin-1 inhibitor in the treatment of rheumatoid arthritisS Kary, G R Burmester
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|April 15, 2014
[Not Available]S Kary, G-R Burmester
Bulletin of Environmental Contamination and Toxicology|December 1, 1989
Toxicological aspects of activated sludge feedingE Nachtomi, B Lipstein, S Kary
Der Internist|December 16, 2003
[Pharmacotherapy of rheumatic diseases in the aged]S Kary, F Buttgereit, G R Burmester
Rheumatology (Oxford, England)|June 10, 2004
Do we still miss the chance of effectively treating early rheumatoid arthritis? New answers from a new studyS Kary, J Fritz, H U Scherer, et al.
Annals of the Rheumatic Diseases|July 30, 2008
Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label studyM Rudwaleit, E Rødevand, P Holck, et al.
Rheumatology (Oxford, England)|May 17, 2007
Effectiveness of adalimumab for rheumatoid arthritis in patients with a history of TNF-antagonist therapy in clinical practiceS Bombardieri, A A Ruiz, P Fardellone, et al.
Annals of the Rheumatic Diseases|September 10, 2005
New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor alpha antagonistsS Kary, M Worm, H Audring, et al.
The British Journal of Dermatology|February 16, 2007
Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonistsH-H Lee, I-H Song, M Friedrich, et al.
Pageof 2